Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I get the impression that thieves run this company
They couldn't earn money the manly way eh.... Had to do it the Zalinsky Way "Give me Credit"
Personally, i think that was as high as it was gonna go for a lonnnnnnng while....lol....
Lol we shall see my friend
Oh I just saw it, that was before they did the split ... Anyhow, there should be another opportunity to make it, GOD willing ... ;)
That was pre reverse split. Now my target would be 50+... my buy in average was about $11 after split..
I was going to average down, i was thinking about it yesterday too... guess i missed the opportunity to make 2-3k which is what i would havec made had i averaged down with another 4-600$
YOUR WISH CAME TRUE AND SOME 3X ... :))))))))))))))))))))))
AZTR
MOTHER TUCKER
DON'T YOU DARE
AZTR 9 BUCKS...ALL OUT
What's the news on the street today... "notice of effectiveness"
CEO purchased shares on the offering at .30, not many do that
slowly but surely
strange pos indeed
I find it strange too release such good
News on a Friday, rather than Monday, unless more is expected, it’s obviously Friday is always a pull out day.
Enjoy your day
bs day friday worth to watch
Imagine waking up one day and this one is trading at 2-$4 per share due to some buyout or pharma deal, or sale of intellectual property like patents/ research etc or FDA Approval and hellllo 100s of millions of gain to market cap lol
I'd keep an eye on this one. Conducting a few presentations in May regarding their be data... could be ripe for some liquidity events IE Buyout or pharma deals
28M O/S 3M float. The company has 12.5 months of cash left based on quarterly cash burn of -$1.59M and estimated current cash of $6.6M (https://dilutiontracker.com/app/search/AZTR).
AZTR..............................https://stockcharts.com/h-sc/ui?s=AZTR&p=W&b=5&g=0&id=p86431144783
Azitra Inc NYSE American: AZTR
GoSymbol lookup
Health Care : Biotechnology | Company profile
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.
Followers
|
7
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
43
|
Created
|
06/05/23
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |